MK‐6, a novel not‐α IL‐2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance
暂无分享,去创建一个
N. Tanaka | M. Kobayashi | K. Murayama | T. Koyama | T. Takeshita | K. Kojima | T. Fukuhara | Yuji Amano | N. Ogama | Naoko Ogama